Viewing Study NCT03616912


Ignite Creation Date: 2025-12-26 @ 10:45 PM
Ignite Modification Date: 2026-03-04 @ 6:35 AM
Study NCT ID: NCT03616912
Status: TERMINATED
Last Update Posted: 2023-01-30
First Post: 2018-08-01
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus
Sponsor: Eli Lilly and Company
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Systemic Lupus Erythematosus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None SLE View